Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IDS goes for experience with new CEO Patrik Dahlen

This article was originally published in Clinica

Executive Summary

A week after Ian Cookson stepped down as CEO of UK vitamin D testing specialist Immunodiagnostics Systems (IDS), the firm has named Dako and Perkin Elmer veteran Patrik Dahlen as its new leader. Mr Dahlen has been a member of IDS's board since December 2009; a spokesperson for the company told Clinica that his promotion to CEO was not part of a longer-term succession plan, but that Mr Dahlen "became the sensible choice" after Mr Cookson's resignation on 25 June "by mutual consent" after nearly two years in the post. At the time, the company said it was in discussions with a candidate with "substantial diagnostic and international industry experience".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT099086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel